SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.334
EU - Europa 1.996
AS - Asia 1.552
SA - Sud America 9
AF - Africa 6
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.312
CN - Cina 854
UA - Ucraina 578
GB - Regno Unito 343
SG - Singapore 340
TR - Turchia 307
DE - Germania 284
IT - Italia 226
SE - Svezia 139
FI - Finlandia 135
PL - Polonia 133
BE - Belgio 39
FR - Francia 33
AT - Austria 28
CA - Canada 21
NL - Olanda 15
IR - Iran 14
RU - Federazione Russa 10
IN - India 9
BR - Brasile 8
LT - Lituania 8
KR - Corea 7
CZ - Repubblica Ceca 6
ES - Italia 5
HK - Hong Kong 4
ID - Indonesia 4
NZ - Nuova Zelanda 4
RO - Romania 4
VN - Vietnam 4
EU - Europa 3
JP - Giappone 3
MZ - Mozambico 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
LI - Liechtenstein 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CH - Svizzera 1
EG - Egitto 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 10.907
Salva come PNG Salva come JPEG
Città #
Woodbridge 891
Fairfield 841
Jacksonville 619
Houston 590
Chandler 504
Ann Arbor 458
Ashburn 410
Santa Clara 378
Wilmington 331
Seattle 328
Cambridge 282
Singapore 272
Nanjing 194
Beijing 193
Izmir 188
New York 142
Princeton 134
Warsaw 133
San Diego 87
Boardman 60
Shenyang 58
Shanghai 56
Milan 55
Nanchang 47
Brussels 39
Tianjin 39
Hebei 38
Jiaxing 37
Los Angeles 36
San Mateo 34
Ferrara 32
Vienna 28
Changsha 26
Helsinki 24
Jinan 23
Ningbo 23
Norwalk 20
Falls Church 19
Washington 18
Mountain View 17
Philadelphia 16
Dearborn 15
Kunming 15
Leawood 15
Auburn Hills 14
Augusta 14
London 14
Guangzhou 13
Orange 12
Munich 11
Redwood City 11
Taizhou 11
Toronto 11
Verona 11
Zhengzhou 11
Ardabil 10
Bologna 9
Monmouth Junction 8
Des Moines 7
Frankfurt am Main 7
Indiana 7
Ottawa 7
Bremen 6
Hangzhou 6
Addison 5
Brno 5
Haikou 5
Lanzhou 5
Changchun 4
Jakarta 4
Rome 4
São Paulo 4
Acton 3
Amsterdam 3
Auckland 3
Bari 3
Chicago 3
Chimoio 3
Dong Ket 3
Hong Kong 3
Meda 3
Minamiyukigaya 3
Napoli 3
Novosibirsk 3
Paris 3
Pieve Emanuele 3
Taiyuan 3
Wandsworth 3
Düsseldorf 2
Genoa 2
Hounslow 2
Las Vegas 2
Madrid 2
New Delhi 2
North Bergen 2
Pearland 2
Piscataway 2
Pune 2
Roseto Degli Abruzzi 2
Sofia 2
Totale 8.073
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 198
null 179
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 162
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 147
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 147
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 136
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 134
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 134
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 133
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 132
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 131
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 130
Herpes Simplex Virus Growth, Preparation, and Assay 130
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 125
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 125
HSV as a vector in vaccine development and gene therapy 123
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 122
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 120
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 119
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 119
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 118
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 117
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 116
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 116
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 115
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 115
Replication-competent herpes simplex vectors: design and applications 115
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 114
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 112
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 112
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 109
Herpesvirus/retrovirus chimeric vectors 108
HSV as a vector in vaccine development and gene therapy 108
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 108
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 107
MEMBRANE PROTEIN PATTERN IN HEREDITARY SPHEROCYTOSIS IN FIVE SUBJECTS FROM NORTH-EAST ITALY OBTAINED BY SDS-PAGE USING N,N'-DIALLYLTARTARDIAMIDE 107
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 107
null 107
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 105
Purinergic Signaling: A New Pharmacological Target Against Viruses? 105
null 104
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 104
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 104
null 104
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 102
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 101
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 101
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 101
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 100
null 99
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 97
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 97
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 96
State of viral DNA in BK virus-transformed rabbit cells 96
Capitolo 55 Retrovirus 95
null 95
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 94
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 94
Virus erpetici come vettori vaccinali 91
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 91
HSV-1 virions engineered for specific binding to cell surface receptors 89
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 89
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 89
null 89
null 88
null 88
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 87
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 85
null 83
null 81
null 80
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 79
Molecular diagnosis of herpes simplex encephalitis 79
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 78
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 77
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 76
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 76
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 76
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 75
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 72
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 71
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 70
Capitolo 44 Herpesviridae 68
Niosomes containing HSV immunogens as possible vaccine against genital herpes 68
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 68
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 66
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 65
Transformation by defined regions of herpes simplex virus DNA. 65
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 63
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 63
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 62
Gene therapy of the nervous system by herpes virus vectors 62
Ocular disease patterns caused by genetically related mutants of Herpes simplex virus type 1. 62
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 61
Niosomes for vaginal administration of an antiherpetic peptide 61
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 61
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 60
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 58
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 58
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 58
Totale 9.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.224
Totale 53.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.026 0 0 0 0 0 0 180 244 148 238 176 40
2020/20211.461 136 124 69 152 66 173 65 175 24 175 227 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/2025922 59 48 186 88 280 249 12 0 0 0 0 0
Totale 11.001